Europe Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others)
The Europe radioactive tracer market was valued at US$ 4,175.25 million in 2022 and is expected to reach US$ 16,098.93 million by 2030; it is estimated to grow at a CAGR of 18.4% from 2022 to 2030.
Use of Radioactive Tracer in Cancer Diagnosis fuel the Europe Radioactive Tracer Market
Oncology is a significantly developing field in the healthcare sector, as cancer cases are increasing worldwide. According to Institute for Health Metrics and Evaluation (IHME), cancer is the second major cause of death after cardiovascular disorders. The use of advanced materials and drugs in the diagnosis and treatment of cancer has surged with prominent developments in oncology. Radioactive tracer-based imaging is one of the advanced diagnostic methods used to accurately diagnose cancer types, such as prostate cancer, gynecological cancer, and blood-borne cancer. Once injected into the body, these radioactive tracers attach to the cancer-specific sites, accurately diagnosing the cancer type. Tracer also helps determine the cancer development stage, enabling effective treatment and faster recovery in most cases. PET and SPECT are among the nuclear imaging techniques that use gamma emitters for detecting tumors. As the tumor grows, its uptake of the PET and SPECT conjugate increases over time, which improves contrast due to the presence of nuclear imaging agents. This further leads to blood clearance due to which clear diagnostic images can be generated. The most commonly used radioactive tracer for detecting cancer is F-18 fluorodeoxyglucose (18F-FDG), a compound similar to glucose or sugar. Cancer cells are highly active and need more energy, i.e., extra glucose, than normal cells. Imaging devices such as PET or SPECT detect this energy released by FDG to create an image showing the location of a radioactive tracer in the body. This helps determine the location of cancerous cells in the patient’s body so that the treatment can be tailored according to the type and stage of cancer. Thus, the increasing use of radioactive tracer in cancer diagnostics is anticipated to drive market expansion during the estimated timeframe.
Europe Radioactive Tracer Market Overview
The Europe radioactive tracer market is sub-segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The regional market growth is associated with such as rising prevalence of neurologic disorders such as, Alzheimer’s and others along with the developments made by the players operating in the region.
Europe Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)
Europe Radioactive Tracer Market Segmentation
The Europe radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the Europe radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.
Based on test type, the Europe radioactive tracer market is segmented into PET, SPECT, and others. The SPECT segment held the largest market share in 2022.
Based on end user, the Europe radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.
Based on application, the Europe radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.
Based on country, the Europe radioactive tracer market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe radioactive tracer market share in 2022.
Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, ABX advanced biochemical compounds GmbH, Novartis AG, Curium, Blue Earth Diagnostics Limited, General Electric Co, and IBA Radiopharma Solutions are some of the leading companies operating in the Europe radioactive tracer market.
Use of Radioactive Tracer in Cancer Diagnosis fuel the Europe Radioactive Tracer Market
Oncology is a significantly developing field in the healthcare sector, as cancer cases are increasing worldwide. According to Institute for Health Metrics and Evaluation (IHME), cancer is the second major cause of death after cardiovascular disorders. The use of advanced materials and drugs in the diagnosis and treatment of cancer has surged with prominent developments in oncology. Radioactive tracer-based imaging is one of the advanced diagnostic methods used to accurately diagnose cancer types, such as prostate cancer, gynecological cancer, and blood-borne cancer. Once injected into the body, these radioactive tracers attach to the cancer-specific sites, accurately diagnosing the cancer type. Tracer also helps determine the cancer development stage, enabling effective treatment and faster recovery in most cases. PET and SPECT are among the nuclear imaging techniques that use gamma emitters for detecting tumors. As the tumor grows, its uptake of the PET and SPECT conjugate increases over time, which improves contrast due to the presence of nuclear imaging agents. This further leads to blood clearance due to which clear diagnostic images can be generated. The most commonly used radioactive tracer for detecting cancer is F-18 fluorodeoxyglucose (18F-FDG), a compound similar to glucose or sugar. Cancer cells are highly active and need more energy, i.e., extra glucose, than normal cells. Imaging devices such as PET or SPECT detect this energy released by FDG to create an image showing the location of a radioactive tracer in the body. This helps determine the location of cancerous cells in the patient’s body so that the treatment can be tailored according to the type and stage of cancer. Thus, the increasing use of radioactive tracer in cancer diagnostics is anticipated to drive market expansion during the estimated timeframe.
Europe Radioactive Tracer Market Overview
The Europe radioactive tracer market is sub-segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The regional market growth is associated with such as rising prevalence of neurologic disorders such as, Alzheimer’s and others along with the developments made by the players operating in the region.
Europe Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)
Europe Radioactive Tracer Market Segmentation
The Europe radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the Europe radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.
Based on test type, the Europe radioactive tracer market is segmented into PET, SPECT, and others. The SPECT segment held the largest market share in 2022.
Based on end user, the Europe radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.
Based on application, the Europe radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.
Based on country, the Europe radioactive tracer market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe radioactive tracer market share in 2022.
Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, ABX advanced biochemical compounds GmbH, Novartis AG, Curium, Blue Earth Diagnostics Limited, General Electric Co, and IBA Radiopharma Solutions are some of the leading companies operating in the Europe radioactive tracer market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE RADIOACTIVE TRACER MARKET - KEY INDUSTRY DYNAMICS
4.1 Key Market Drivers:
4.1.1 Rising Prevalence of Chronic Diseases
4.1.2 Increasing Use of Nuclear Imaging Techniques
4.2 Market Restraints
4.2.1 Short Shelf-Life of Radioactive Tracer
4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
4.3 Market Opportunities
4.3.1 New Initiatives for Radioactive Tracer R&D
4.4 Future Trends
4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
4.5 Impact Analysis:
5. RADIOACTIVE TRACER MARKET - EUROPE MARKET ANALYSIS
5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 – 2030
6. EUROPE RADIOACTIVE TRACER MARKET – REVENUE AND FORECAST TO 2030 – BY TRACER TYPES
6.1 Overview
6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
6.3 Technetium 99m and TC-97m
6.3.1 Overview
6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Iodine
6.4.1 Overview
6.4.2 Iodine 131: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Iron
6.5.1 Overview
6.5.2 Iron 59: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Lutetium-
6.6.1 Overview
6.6.2 Lutetium- 171: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.7 RB82 and ammonia N-13
6.7.1 Overview
6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.8 Scandium
6.8.1 Overview
6.8.2 Scandium 46: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.9 Seaborgium-269
6.9.1 Overview
6.9.2 Seaborgium-269: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.10 Hassium -269
6.10.1 Overview
6.10.2 Hassium -269: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.11 Gallium Citrate GA
6.11.1 Overview
6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.12 PSMA GA68
6.12.1 Overview
6.12.2 PSMA GA68: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.13 FDDNP (F-18) and FDOPA (f-18)
6.13.1 Overview
6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.14 Phosphorus 32 and Chromium -51
6.14.1 Overview
6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.15 Thallium-201
6.15.1 Overview
6.15.2 Thallium-201: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.16 F-18 FDG
6.16.1 Overview
6.16.2 F-18 FDG: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.17 F-18 FAPI
6.17.1 Overview
6.17.2 F-18 FAPI: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.18 GA 68 FAPI
6.18.1 Overview
6.18.2 GA 68 FAPI: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.19 F-18 PSMA
6.19.1 Overview
6.19.2 F-18 PSMA: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.20 DOTATOC/DOTANOC/DOTATATE Ga
6.20.1 Overview
6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.21 Others
6.21.1 Overview
6.21.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7. EUROPE RADIOACTIVE TRACER MARKET – REVENUE AND FORECAST TO 2030 – BY TEST TYPE
7.1 Overview
7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 PET
7.3.1 Overview
7.3.2 PET: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7.4 SPECT
7.4.1 Overview
7.4.2 SPECT: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8. EUROPE RADIOACTIVE TRACER MARKET – REVENUE AND FORECAST TO 2030 – BY APPLICATION.
8.1 Overview
8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Pulmonary
8.4.1 Overview
8.4.2 Pulmonary: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Neurology
8.5.1 Overview
8.5.2 Neurology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9. EUROPE RADIOACTIVE TRACER MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
9.1 Overview
9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Centers
9.4.1 Overview
9.4.2 Diagnostic Centers: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
10. EUROPE RADIOACTIVE TRACER MARKET - COUNTRY ANALYSIS
10.1 Europe Radioactive Tracer Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.2 Europe Radioactive Tracer Market by Country
10.1.2.1 Germany
10.1.2.1.1 Overview
10.1.2.1.2 Germany Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1.3 Germany Radioactive Tracer Market, by Tracer Types
10.1.2.1.4 Germany Radioactive Tracer Market, by Test Type
10.1.2.1.5 Germany Radioactive Tracer Market, by Application
10.1.2.1.6 Germany Radioactive Tracer Market, by End-User
10.1.2.2 UK
10.1.2.2.1 Overview
10.1.2.2.2 UK Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 UK Radioactive Tracer Market, by Tracer Types
10.1.2.2.4 UK Radioactive Tracer Market, by Test Type
10.1.2.2.5 UK Radioactive Tracer Market, by Application
10.1.2.2.6 UK Radioactive Tracer Market, by End-User
10.1.2.3 France
10.1.2.3.1 Overview
10.1.2.3.2 France Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 France Radioactive Tracer Market, by Tracer Types
10.1.2.3.4 France Radioactive Tracer Market, by Test Type
10.1.2.3.5 France Radioactive Tracer Market, by Application
10.1.2.3.6 France Radioactive Tracer Market, by End-User
10.1.2.4 Italy
10.1.2.4.1 Overview
10.1.2.4.2 Italy Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.3 Italy Radioactive Tracer Market, by Tracer Types
10.1.2.4.4 Italy Radioactive Tracer Market, by Test Type
10.1.2.4.5 Italy Radioactive Tracer Market, by Application
10.1.2.4.6 Italy Radioactive Tracer Market, by End-User
10.1.2.5 Spain
10.1.2.5.1 Overview
10.1.2.5.2 Spain Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.5.3 Spain Radioactive Tracer Market, by Tracer Types
10.1.2.5.4 Spain Radioactive Tracer Market, by Test Type
10.1.2.5.5 Spain Radioactive Tracer Market, by Application
10.1.2.5.6 Spain Radioactive Tracer Market, by End-User
10.1.2.6 Rest of Europe
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Europe Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.3 Rest of Europe Radioactive Tracer Market, by Tracer Types
10.1.2.6.4 Rest of Europe Radioactive Tracer Market, by Test Type
10.1.2.6.5 Rest of Europe Radioactive Tracer Market, by Application
10.1.2.6.6 Rest of Europe Radioactive Tracer Market, by End-User
11. RADIOACTIVE TRACER MARKET INDUSTRY LANDSCAPE
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. RADIOACTIVE TRACER MARKET, KEY COMPANY PROFILES
12.1 Rotem Industries Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 ABX advanced biochemical compounds GmbH
12.2.1 Business Description
12.2.2 Products and Services
12.2.3 Financial Overview
12.2.4 SWOT Analysis
12.2.5 Key Developments
12.3 Invicro LLC
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cardinal Health Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Newcastle University
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Novartis AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Curium
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Blue Earth Diagnostics Limited
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 General Electric Co
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 IBA Radiopharma Solutions
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE RADIOACTIVE TRACER MARKET - KEY INDUSTRY DYNAMICS
4.1 Key Market Drivers:
4.1.1 Rising Prevalence of Chronic Diseases
4.1.2 Increasing Use of Nuclear Imaging Techniques
4.2 Market Restraints
4.2.1 Short Shelf-Life of Radioactive Tracer
4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
4.3 Market Opportunities
4.3.1 New Initiatives for Radioactive Tracer R&D
4.4 Future Trends
4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
4.5 Impact Analysis:
5. RADIOACTIVE TRACER MARKET - EUROPE MARKET ANALYSIS
5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 – 2030
6. EUROPE RADIOACTIVE TRACER MARKET – REVENUE AND FORECAST TO 2030 – BY TRACER TYPES
6.1 Overview
6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
6.3 Technetium 99m and TC-97m
6.3.1 Overview
6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Iodine
6.4.1 Overview
6.4.2 Iodine 131: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Iron
6.5.1 Overview
6.5.2 Iron 59: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Lutetium-
6.6.1 Overview
6.6.2 Lutetium- 171: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.7 RB82 and ammonia N-13
6.7.1 Overview
6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.8 Scandium
6.8.1 Overview
6.8.2 Scandium 46: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.9 Seaborgium-269
6.9.1 Overview
6.9.2 Seaborgium-269: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.10 Hassium -269
6.10.1 Overview
6.10.2 Hassium -269: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.11 Gallium Citrate GA
6.11.1 Overview
6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.12 PSMA GA68
6.12.1 Overview
6.12.2 PSMA GA68: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.13 FDDNP (F-18) and FDOPA (f-18)
6.13.1 Overview
6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.14 Phosphorus 32 and Chromium -51
6.14.1 Overview
6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.15 Thallium-201
6.15.1 Overview
6.15.2 Thallium-201: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.16 F-18 FDG
6.16.1 Overview
6.16.2 F-18 FDG: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.17 F-18 FAPI
6.17.1 Overview
6.17.2 F-18 FAPI: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.18 GA 68 FAPI
6.18.1 Overview
6.18.2 GA 68 FAPI: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.19 F-18 PSMA
6.19.1 Overview
6.19.2 F-18 PSMA: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.20 DOTATOC/DOTANOC/DOTATATE Ga
6.20.1 Overview
6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.21 Others
6.21.1 Overview
6.21.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7. EUROPE RADIOACTIVE TRACER MARKET – REVENUE AND FORECAST TO 2030 – BY TEST TYPE
7.1 Overview
7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 PET
7.3.1 Overview
7.3.2 PET: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7.4 SPECT
7.4.1 Overview
7.4.2 SPECT: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8. EUROPE RADIOACTIVE TRACER MARKET – REVENUE AND FORECAST TO 2030 – BY APPLICATION.
8.1 Overview
8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Pulmonary
8.4.1 Overview
8.4.2 Pulmonary: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Neurology
8.5.1 Overview
8.5.2 Neurology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9. EUROPE RADIOACTIVE TRACER MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
9.1 Overview
9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Centers
9.4.1 Overview
9.4.2 Diagnostic Centers: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
10. EUROPE RADIOACTIVE TRACER MARKET - COUNTRY ANALYSIS
10.1 Europe Radioactive Tracer Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.2 Europe Radioactive Tracer Market by Country
10.1.2.1 Germany
10.1.2.1.1 Overview
10.1.2.1.2 Germany Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1.3 Germany Radioactive Tracer Market, by Tracer Types
10.1.2.1.4 Germany Radioactive Tracer Market, by Test Type
10.1.2.1.5 Germany Radioactive Tracer Market, by Application
10.1.2.1.6 Germany Radioactive Tracer Market, by End-User
10.1.2.2 UK
10.1.2.2.1 Overview
10.1.2.2.2 UK Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 UK Radioactive Tracer Market, by Tracer Types
10.1.2.2.4 UK Radioactive Tracer Market, by Test Type
10.1.2.2.5 UK Radioactive Tracer Market, by Application
10.1.2.2.6 UK Radioactive Tracer Market, by End-User
10.1.2.3 France
10.1.2.3.1 Overview
10.1.2.3.2 France Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 France Radioactive Tracer Market, by Tracer Types
10.1.2.3.4 France Radioactive Tracer Market, by Test Type
10.1.2.3.5 France Radioactive Tracer Market, by Application
10.1.2.3.6 France Radioactive Tracer Market, by End-User
10.1.2.4 Italy
10.1.2.4.1 Overview
10.1.2.4.2 Italy Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.3 Italy Radioactive Tracer Market, by Tracer Types
10.1.2.4.4 Italy Radioactive Tracer Market, by Test Type
10.1.2.4.5 Italy Radioactive Tracer Market, by Application
10.1.2.4.6 Italy Radioactive Tracer Market, by End-User
10.1.2.5 Spain
10.1.2.5.1 Overview
10.1.2.5.2 Spain Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.5.3 Spain Radioactive Tracer Market, by Tracer Types
10.1.2.5.4 Spain Radioactive Tracer Market, by Test Type
10.1.2.5.5 Spain Radioactive Tracer Market, by Application
10.1.2.5.6 Spain Radioactive Tracer Market, by End-User
10.1.2.6 Rest of Europe
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Europe Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.3 Rest of Europe Radioactive Tracer Market, by Tracer Types
10.1.2.6.4 Rest of Europe Radioactive Tracer Market, by Test Type
10.1.2.6.5 Rest of Europe Radioactive Tracer Market, by Application
10.1.2.6.6 Rest of Europe Radioactive Tracer Market, by End-User
11. RADIOACTIVE TRACER MARKET INDUSTRY LANDSCAPE
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. RADIOACTIVE TRACER MARKET, KEY COMPANY PROFILES
12.1 Rotem Industries Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 ABX advanced biochemical compounds GmbH
12.2.1 Business Description
12.2.2 Products and Services
12.2.3 Financial Overview
12.2.4 SWOT Analysis
12.2.5 Key Developments
12.3 Invicro LLC
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cardinal Health Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Newcastle University
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Novartis AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Curium
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Blue Earth Diagnostics Limited
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 General Electric Co
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 IBA Radiopharma Solutions
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
